Scholars Central

Mini reviewPublished 29 Nov 2022

Role of Fibroblast Growth Factor (FGF) in Suppressing Tumor in Patients with Colorectal Cancer

Authors: Charlie Javice

University of East Anglia, Norwich Research Park, Norwich, United Kingdom

World Journal of Pharmacology and Toxicology

Volume 5 · Issue 6 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In colorectal cancer, fibroblast growth factor 14 (FGF14) was selectively methylated (CRC). In this work, we sought to elucidate the biological action, molecular mechanism, and epigenetic control of FGF14 in CRC. By using PCR and Western blot, the expression of FGF14 in CRC cell lines, normal human colon epithelial cell lines, CRC tissues, and matched neighbouring normal tissues was found. FGF14 blocked the PI3K/AKT/mTOR pathway and caused mitochondrial death. In conclusion, FGF14 is a new tumour suppressor that activates the PI3K/AKT/mTOR pathway to mediate cell death and restrict cell growth.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in World Journal of Pharmacology and Toxicology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalWorld Journal of Pharmacology and Toxicology
  • SubjectPharmaceutical Sciences
  • SubjectToxicology
  • BylineArticles whose byline prints “Charlie Javice”